Fisher & Paykel Healthcare Gestione
Gestione criteri di controllo 3/4
Fisher & Paykel Healthcare Il CEO è Lewis Gradon, nominato in Apr2016, e ha un mandato di 8.58 anni. la retribuzione annua totale è NZ$ 3.53M, composta da 50.6% di stipendio e 49.4% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 0.098% delle azioni della società, per un valore di NZ$ 21.81M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.5 anni e 4.5 anni.
Informazioni chiave
Lewis Gradon
Amministratore delegato
NZ$3.5m
Compenso totale
| Percentuale dello stipendio del CEO | 50.6% |
| Mandato del CEO | 8.6yrs |
| Proprietà del CEO | 0.1% |
| Durata media del management | 3.5yrs |
| Durata media del Consiglio di amministrazione | 4.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
The Returns On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Don't Inspire Confidence
Oct 28
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Shares May Have Run Too Fast Too Soon
Oct 08Here's Why Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Compensation Is The Least Of Shareholders Concerns
Aug 21Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jul 29Fisher & Paykel Healthcare (NZSE:FPH) Will Want To Turn Around Its Return Trends
Jul 11Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Investors Are Less Pessimistic Than Expected
Jun 22There May Be Reason For Hope In Fisher & Paykel Healthcare's (NZSE:FPH) Disappointing Earnings
Jun 05Is Fisher & Paykel Healthcare (NZSE:FPH) Using Too Much Debt?
Mar 27Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Feb 22Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) Business Is Yet to Catch Up With Its Share Price
Feb 05Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jan 03We Think Fisher & Paykel Healthcare (NZSE:FPH) Can Stay On Top Of Its Debt
Nov 30Fisher & Paykel Healthcare (NZSE:FPH) Could Be Struggling To Allocate Capital
Nov 12Estimating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Aug 28Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
Aug 10Here's Why Fisher & Paykel Healthcare (NZSE:FPH) Can Manage Its Debt Responsibly
Jul 02Be Wary Of Fisher & Paykel Healthcare (NZSE:FPH) And Its Returns On Capital
May 01Returns On Capital Signal Tricky Times Ahead For Fisher & Paykel Healthcare (NZSE:FPH)
Jan 23Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Dec 27Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Oct 28Shareholders Are Optimistic That Fisher & Paykel Healthcare (NZSE:FPH) Will Multiply In Value
Oct 13Fisher & Paykel Healthcare (NZSE:FPH) Has A Pretty Healthy Balance Sheet
Sep 28Calculating The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Jul 24A Look Into Fisher & Paykel Healthcare's (NZSE:FPH) Impressive Returns On Capital
Jul 10Fisher & Paykel Healthcare (NZSE:FPH) Seems To Use Debt Quite Sensibly
Jun 12A Look At The Fair Value Of Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH)
Apr 17Fisher & Paykel Healthcare (NZSE:FPH) Could Become A Multi-Bagger
Apr 04Does Fisher & Paykel Healthcare (NZSE:FPH) Have A Healthy Balance Sheet?
Mar 06With EPS Growth And More, Fisher & Paykel Healthcare (NZSE:FPH) Is Interesting
Jan 22Why The 41% Return On Capital At Fisher & Paykel Healthcare (NZSE:FPH) Should Have Your Attention
Dec 26Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Dec 05This Is The Reason Why We Think Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) CEO Deserves A Bump Up To Their Compensation
Aug 11Is Fisher & Paykel Healthcare Corporation Limited (NZSE:FPH) Worth NZ$31.6 Based On Its Intrinsic Value?
Aug 01Do Fisher & Paykel Healthcare's (NZSE:FPH) Earnings Warrant Your Attention?
Jul 07Is Fisher & Paykel Healthcare (NZSE:FPH) A Risky Investment?
Jun 24Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Mar 31 2024 | NZ$4m | NZ$2m | NZ$133m |
| Dec 31 2023 | n/a | n/a | NZ$197m |
| Sep 30 2023 | n/a | n/a | NZ$262m |
| Jun 30 2023 | n/a | n/a | NZ$256m |
| Mar 31 2023 | NZ$3m | NZ$2m | NZ$250m |
| Dec 31 2022 | n/a | n/a | NZ$251m |
| Sep 30 2022 | n/a | n/a | NZ$251m |
| Jun 30 2022 | n/a | n/a | NZ$314m |
| Mar 31 2022 | NZ$4m | NZ$2m | NZ$377m |
| Dec 31 2021 | n/a | n/a | NZ$449m |
| Sep 30 2021 | n/a | n/a | NZ$521m |
| Jun 30 2021 | n/a | n/a | NZ$522m |
| Mar 31 2021 | NZ$4m | NZ$2m | NZ$524m |
| Dec 31 2020 | n/a | n/a | NZ$458m |
| Sep 30 2020 | n/a | n/a | NZ$392m |
| Jun 30 2020 | n/a | n/a | NZ$339m |
| Mar 31 2020 | NZ$3m | NZ$1m | NZ$287m |
| Dec 31 2019 | n/a | n/a | NZ$260m |
| Sep 30 2019 | n/a | n/a | NZ$233m |
| Jun 30 2019 | n/a | n/a | NZ$221m |
| Mar 31 2019 | NZ$3m | NZ$1m | NZ$209m |
| Dec 31 2018 | n/a | n/a | NZ$208m |
| Sep 30 2018 | n/a | n/a | NZ$206m |
| Jun 30 2018 | n/a | n/a | NZ$198m |
| Mar 31 2018 | NZ$2m | NZ$993k | NZ$190m |
Compensazione vs Mercato: La retribuzione totale di Lewis ($USD 2.10M ) è inferiore alla media delle aziende di dimensioni simili nel mercato NZ ($USD 4.41M ).
Compensazione vs guadagni: La retribuzione di Lewis è aumentata di oltre il 20%, mentre gli utili aziendali sono diminuiti di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Lewis Gradon (63 yo)
8.6yrs
Mandato
NZ$3,533,971
Compensazione
Mr. Lewis G. Gradon has been the Chief Executive Officer, Managing Director & Executive Director at Fisher & Paykel Healthcare Corporation Limited since April 1, 2016. He served as the Senior Vice Presiden...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 21.8m | |
| Chief Financial Officer | 5.7yrs | Nessun dato | 0.0045% NZ$ 1.0m | |
| COO & GM of Respiratory Humidification | less than a year | Nessun dato | 0.00060% NZ$ 133.6k | |
| Vice President of Products & Technology | 8.6yrs | Nessun dato | 0.019% NZ$ 4.2m | |
| Head of Capital Markets & Investor Relations | no data | Nessun dato | Nessun dato | |
| Company Secretary & General Counsel | less than a year | Nessun dato | Nessun dato | |
| Senior Communications & Investor Relations Manager | no data | Nessun dato | Nessun dato | |
| VP of Sales & Marketing and President of North America & Europe | less than a year | Nessun dato | 0.029% NZ$ 6.4m | |
| Vice President of Human Resources | 4.1yrs | Nessun dato | Nessun dato | |
| Vice President of Supply Chain | 2.8yrs | Nessun dato | Nessun dato | |
| Vice President of Corporate | no data | Nessun dato | Nessun dato | |
| General Manager of Airvo Optiflow | no data | Nessun dato | Nessun dato |
3.5yrs
Durata media
Gestione esperta: Il team dirigenziale di FPH è considerato esperto (durata media dell'incarico 3.5 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| MD, CEO & Executive Director | 8.6yrs | NZ$3.53m | 0.098% NZ$ 21.8m | |
| Non-Executive Director | 23yrs | NZ$188.15k | 0.15% NZ$ 34.2m | |
| Independent Chairman of the Board | 6yrs | NZ$220.74k | 0.0013% NZ$ 282.8k | |
| Independent Non-Executive Director | 3.1yrs | NZ$212.77k | 0.0023% NZ$ 514.4k | |
| Member of EcoDesign Advisory Board | no data | Nessun dato | Nessun dato | |
| Non-Executive Director | less than a year | Nessun dato | Nessun dato | |
| Non-Executive Independent Director | 1.1yrs | NZ$93.48k | 0.00032% NZ$ 71.3k | |
| Independent Non-Executive Director | 7.4yrs | NZ$179.08k | 0.00065% NZ$ 144.7k | |
| Independent Non-Executive Director | 2.4yrs | NZ$160.13k | 0.00033% NZ$ 73.5k | |
| Member of EcoDesign Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of EcoDesign Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of EcoDesign Advisory Board | no data | Nessun dato | Nessun dato |
4.5yrs
Durata media
63yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di FPH sono considerati esperti (durata media dell'incarico 4.5 anni).